Dynamic Technology Lab Private LTD Revolution Medicines, Inc. Transaction History

Dynamic Technology Lab Private LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$26.56 - $33.55 $220,979 - $279,136	8,320 New	8,320 $268,000
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $634,485 - $883,540	25,208 New	25,208 $698,000
Q2 2022 Aug 12, 2022	BUY	$14.54 - $27.17 $153,716 - $287,241	10,572 New	10,572 $206,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $154,820 - $236,121	-8,944 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $195,920 - $271,150	-8,046 Reduced 47.36%	8,944 $225,000
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $406,910 - $567,635	16,990 New	16,990 $468,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.